ConductScience.org, home

Paper42455481

Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies.

Marques BS and 4 others. Mol Diagn Ther, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies. Papers, record 42455481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42455481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies.
PubMed
Journal
Mol Diagn Ther
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marques BSBárbara S
2Mendes MMaria
3Alves JLJosé Luís
4Pais AAlberto
5Vitorino CCarlahttps://orcid.org/0000-0003-3424-548X

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TemozolomideMajor topic
Drug Resistance, NeoplasmMajor topic
CRISPR-Cas SystemsMajor topic
Antineoplastic Agents, AlkylatingMajor topic
GlioblastomaMajor topic
Brain NeoplasmsMajor topic
Humans
Animals

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022.06174.PTDCFundação para a Ciência e a TecnologiaPubMed
UID/PRR/00313/2025Fundação para a Ciência e a TecnologiaPubMed
UID/00313/2025Fundação para a Ciência e a TecnologiaPubMed

Source PubMed

Download CSV of grants

References89

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
141580561The impact of AI on modern oncology from early detection to personalized cancer treatment.NPJ Precis Oncol2026https://conductscience.org/library/papers/41580561PubMed
241232838Integrating computational pathology and multi-transcriptomics to characterize glioblastoma heterogeneity and identify prognostic biomarkers.Hum Pathol2025https://conductscience.org/library/papers/41232838PubMed
338326875IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy.Genome Biol2024https://conductscience.org/library/papers/38326875PubMed
431637166The CRISPR-Cas13a Gene-Editing System Induces Collateral Cleavage of RNA in Glioma Cells.Adv Sci (Weinh)2019https://conductscience.org/library/papers/31637166PubMed
525263330CRISPR-Cas9 knockin mice for genome editing and cancer modeling.Cell2014https://conductscience.org/library/papers/25263330PubMed
639209994Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR-Cas gene editing.Nat Nanotechnol2024https://conductscience.org/library/papers/39209994PubMed
738357209Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cells.Front Oncol2024https://conductscience.org/library/papers/38357209PubMed
839078737A simple and scalable zebrafish model of Sonic hedgehog medulloblastoma.Cell Rep2024https://conductscience.org/library/papers/39078737PubMed
930995489Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.Cell Rep2019https://conductscience.org/library/papers/30995489PubMed
1025119044CRISPR-mediated direct mutation of cancer genes in the mouse liver.Nature2014https://conductscience.org/library/papers/25119044PubMed
1140697666CRISPR/Cas9 technology in tumor research and drug development application progress and future prospects.Front Pharmacol2025https://conductscience.org/library/papers/40697666PubMed
1238134889Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents.Neuro Oncol2024https://conductscience.org/library/papers/38134889PubMed
1339799395Efficient gene delivery admitted by small metabolites specifically targeting astrocytes in the mouse brain.Mol Ther2025https://conductscience.org/library/papers/39799395PubMed
1434337348Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review.Cancer Drug Resist2021https://conductscience.org/library/papers/34337348PubMed
1538861272Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma.ACS Nano2024https://conductscience.org/library/papers/38861272PubMed
1639821288Myt1 Kinase: An Emerging Cell-Cycle Regulator for Cancer Therapeutics.Clin Cancer Res2025https://conductscience.org/library/papers/39821288PubMed
1740050992Large-scale CRISPRi screens link metabolic stress to glioblastoma chemoresistance.J Transl Med2025https://conductscience.org/library/papers/40050992PubMed
1833005303CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy.Comput Struct Biotechnol J2020https://conductscience.org/library/papers/33005303PubMed
1926603103Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.Nat Commun2015https://conductscience.org/library/papers/26603103PubMed
2024912512MGMT testing--the challenges for biomarker-based glioma treatment.Nat Rev Neurol2014https://conductscience.org/library/papers/24912512PubMed

See all 89 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MGMT4255PubTator's text mininghttps://conductscience.org/library/genes/4255

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42455481

GET https://conductscience.org/api/papers/v1/42455481/references?page=2